Article

Dr. Bird receives AAO's highest honor

The American Academy of Ophthalmology's highest honor-the 2008 Laureate Recognition Award-has been awarded to Alan C. Bird, MD, for his distinguished career and contributions to ophthalmology.

San Francisco

-The American Academy of Ophthalmology's (AAO) highest honor-the 2008 Laureate Recognition Award-has been awarded to Alan C. Bird, MD, for his distinguished career and contributions to ophthalmology. The award will be presented at this year's joint meeting with the European Society of Ophthalmology (SOE) in Atlanta.

"Dr. Bird is recognized worldwide as a pioneer in ophthalmic research, teaching and clinical medicine," said David Parke, MD, president of the AAO. "In recognition of his contributions to the profession of ophthalmology, we acknowledge the debt we all owe to him for his commitment, which has enabled many of his students to leave their mark on the field."

 Dr. Bird's expertise is in the treatment of retinal vascular disease and genetic and degenerative retinal disorders and has published numerous papers on the topics. His research has made major contributions to the understanding of retinal disease such as retinal dystrophies and age-related macular degeneration.

Earning his medical degree from Guy's Hospital Medical School, London, in 1961 Dr. Bird came to the United States in 1968 under a fellowship at the Bascom Palmer Eye Institute in Miami. Upon returning to London in 1969, he was appointed to the Institute of Ophthalmology as lecturer, and subsequently senior lecturer, reader and professor, and consultant at Moorfields Eye Hospital, where he established a specialized clinical service for retinal disease.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.